文传商讯
![](/images/defaultpic.gif)
Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome
2024-06-20 23:46:58
![](/images/defaultpic.gif)
Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olver
2024-06-17 18:52:00